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Caspase-activated DNase (ICAD) Induces Apoptotic DNA
Fragmentation, Caspase Activation, and Cell Death
A CELL SUICIDEMODULE*
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Background: Regulation and function of the apoptotic nuclease, caspase-activated DNase (CAD), remains obscure.
Results:Rapid depletion of theCAD inhibitor (ICAD) using auxin-inducible degron system induces ectopicCADactivation and
apoptosis.
Conclusion: Ectopic CAD activation triggers caspase activation and apoptosis through a positive feedback loop.
Significance: Controlled CAD dissociation from ICAD is applicable as a novel method to eliminate unwanted cells.
Caspase-activated DNase (CAD) is a major apoptotic nuclease,
responsible for DNA fragmentation and chromatin condensa-
tion during apoptosis. CAD is normally activated in apoptosis as
a result of caspase cleavage of its inhibitory chaperone ICAD.
Other aspects of CAD regulation are poorly understood. In par-
ticular, it has been unclear whether direct CAD activation in
non-apoptotic living cells can trigger cell death. Taking advan-
tage of the auxin-inducible degron (AID) system, we have devel-
oped a suicide system with which ICAD is rapidly degraded in
living cells in response to the plant hormone auxin. Our studies
demonstrate that rapid ICAD depletion is sufficient to activate
CAD and induce cell death in DT40 and yeast cells. In the ver-
tebrate cells, ectopic CAD activation triggered caspase activa-
tion and subsequent hallmarks of caspase-dependent apoptotic
changes, including phosphatidylserine exposure and nuclear
fragmentation. These observations not only suggest that CAD
activationdrives apoptosis through a positive feedback loop, but
also identify a unique suicide system that can be used for con-
trolling gene-modified organisms.
Apoptosis is a cell-autonomous pathway that eliminates
unwanted or damaged cells without harming neighboring tis-
sues. Apoptotic proteases, most notably caspases, play impor-
tant roles in the pathways leading to apoptotic execution (1–4).
To prevent accidental activation of caspases and cell death, cells
have evolved elaborate regulatory mechanisms to regulate
caspase activity (1, 2, 4–9). In addition to apoptotic proteases,
apoptotic nucleases typically function during the execution
phase of apoptosis (10, 11). Importantly, however, the regula-
tion of apoptotic nucleases is less well understood. Although
the action of the caspase-activated DNase (CAD)5 nuclease is
sufficient to drive nuclear events of classical apoptosis such as
DNA fragmentation and apoptotic chromatin condensation
(12), the possibility that activity of this endogenous nuclease by
itself is capable of initiating the death of healthy living cells has
never been tested.
In this study, we describe a synthetic suicide module that is
based on an apoptotic nuclease and can be induced by the addi-
tion of the ubiquitous plant hormone indoleacetic acid (auxin).
This cell suicide module utilizes the major apoptotic nuclease,
CAD (also known as DFF40) (13, 14). The inhibitor of CAD
(ICAD/DFF45) normally forms an inactive complex with CAD.
ICAD has dual roles as a chaperone required for CAD activity
and as an inhibitor that prevents spontaneous CAD activation
in living cells (14). During apoptotic execution (see Fig. 1A),
caspase-3 normally cleaves ICAD at two sites (15). This liber-
ates CAD, allowing it to form an active homo-dimer (16).
Active dimeric CAD cleaves between nucleosomes, inducing
DNA fragmentation and the final stages of apoptotic chromatin
condensation (12). Cells are viable without CAD, and it has
been reported that loss of CAD activity can increase cell sur-
vival. Conversely, CAD overexpression can increase cell death
(17–19). Treatment of acute myeloid leukemia cells with puri-
fied CAD fused with granulocyte/macrophage colony-stimu-
lating factor induced apoptosis (20).Moreover, CAD activation
has been linked to cell death during prolonged mitotic arrest
(21). These studies suggest that ectopicCADactivation in living
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cellsmight induce cell death.However, whether there is a safety
mechanism apart from ICAD to prevent ectopic CAD activa-
tion in living cells has been unclear.
We previously modified ICAD to replace caspase cleavage
sites with tobacco etch virus protease cleavage sites (22). Treat-
ment of themodified ICADwith tobacco etch virus protease led
to CAD activation in vitro, in Escherichia coli, and in yeast
(where endogenous CAD/ICAD are absent) (22, 23). Knowing
that CAD can be activated by ICAD degradation independent
of caspases, we decided to test whether proteasomal degrada-
tion of ICAD in situ is sufficient to activate CAD and to induce
cell death in healthy non-apoptotic cells (see Fig. 1, B and C).
EXPERIMENTAL PROCEDURES
Cell Culture and Transfections—The chicken lymphoma B
cell line DT40 and its ICAD/ knock-out derivative (in which
the entire ICAD ORF is deleted) were cultured as described
previously (22, 24). Transfection to obtain AID-GFP-mICAD-
expressing ICAD knock-out cells (AGI:TIR) was performed as
described previously and selected by the addition of 1.5 mg/ml
G418 (25).
AID Antibody Generation—cDNA encoding amino acids
28–102 of the Arabidopsis thaliana IAA17 protein fused to a
His6 tag in the pET28c vector was transformed into E. coli
BL21 codon plus. After isopropyl--D-1-thiogalactopyranoside
induction, the proteinwas isolated onNi2-agarose, dialyzed at
4 °C into calcium- and magnesium-free Dulbecco’s PBS, cross-
linked by the addition of formaldehyde to 1% for 1 h at 4 °C, and
dialyzed further in PBS to remove unreacted formaldehyde.
Using this cross-linked antigen, murine hybridomas that
secrete anti-AID antibody were generated as described in pre-
vious studies (26) using theMayoClinicHybridomaCore Facil-
ity. Primary screening of culture supernatants was performed
by ELISA using non-cross-linked His6-IAA17 (amino acids
28–102), and secondary screening was performed by immuno-
blotting as described below.
Subcloning, Antibodies, and Drug Treatments—GFP-mI-
CAD-L (12) was cloned into pMK102 (27) using EcoRV and
EcoRI sites. Antibodies used for immunoblotting and indirect
immunofluorescence analysis were our mouse monoclonal
anti-AID tag at 1:1000, rabbit anti-GFP at 1:1000 (Molecular
Probes, Life Technologies), and mouse anti-tubulin B512
(Sigma) at 1:4000. Drugs (final concentration) used were auxin
(indoleacetic acid) at 125 M (Q-Val-Asp-CH2-OPh, non-O-
methylated) in ethanol, etoposide at 10 or 100M (Calbiochem)
in DMSO, and the caspase inhibitor at 10 or 50 M (Calbio-
chem) in DMSO.
Indirect Immunofluorescence of AGI:TIR Cells—Cells were
attached to polylysine-coated slides, fixed in 4% paraformalde-
hyde/PBS, permeabilized with 0.15% Triton X-100 for 2 min,
and blocked with 1% BSA/PBS. Anti-AID antibody (1:1000 in
blocking buffer) and anti-mouse secondary antibody (Alexa
Fluor 594, 1:1000 fromMolecular Probes) were used to visual-
ize the tagged protein. Three-dimensional data sets were
acquired using a cooled CCD camera (CoolSNAP HQ; Photo-
metrics) on a wide-field microscope (DeltaVision RT; Applied
Precision) with a 100NA1.4 Plan Apochromat lens. The data
sets were deconvolved with softWoRx (Applied Precision),
exported as TIFF files, and imported into Adobe Photoshop for
final presentation.
Flow Cytometry—GFP-positive and -negative living cells
were sorted using a FACSAria (BD Biosciences), and analysis
was performed using FACSCalibur or LSRII (BD Biosciences)
flow cytometers.
Annexin V Assay—Cell death was quantified using an
annexin V-phycoerythrin (PE)-CY5 apoptosis detection kit
(BioVision) following the manufacturer’s instructions.
TUNELAssay—DNA fragmentationwas assessed using an In
Situ cell death detection kit, TMR red (Roche Diagnostics
GmbH, Mannheim Germany) for analysis with microscope or
Click-iT TUNEL Alexa Fluor 647 (Life Technologies) for flow
cytometry analysis following the manufacturer’s instructions.
For time course analysis,1 106 cells/sample were collected
and fixed with 4% formaldehyde and then permeabilized with
0.25% Triton X-100.
Genomic DNA-Agarose Gel Electrophoresis—1  107 cells/
sample were treated with indoleacetic acid or 10 M etoposide
for 6 h. Cells were lysed in lysis buffer (200mMTris-HCl pH 7.4,
200 mM EDTA, 1%Nonidet P-40) for 10 s and centrifuged for 5
min to obtain the supernatant. After SDS was added (final: 1%
SDS), samples were treated with proteinase K (final 2.5 g/ml)
overnight at 37 °C. Genomic DNA was precipitated with 1/10
volumes of 10M ammoniumacetate and 2.5 volumes of ethanol.
The precipitate was washed with 70% ethanol, and the final
precipitate was dissolved in Tris-EDTA (TE) buffer containing
5g/ml RNase overnight at 4 °C. Genomic DNAwas loaded on
2% Tris-acetate-EDTA (TAE) agarose gels. DNA was stained
with ethidium bromide.
Colony Formation Assay for DT40 Cells—Cells were treated
for 6 h in the absence or presence of auxin, diluted, and plated in
96-well dishes so that each well contained one living cell. After
1–2 weeks, colonies (positive wells) were counted.
Caspase Activation Assay—3 105cells/sample were treated
with indoleacetic acid for 0–6h in the presence of absence of 10
M caspase inhibitor Q-VD-OPh. Caspase activation was ana-
lyzed using the FLICA 660 in vitro poly caspase detection kit
(ImmunoChemistry Technologies LLC) following the manu-
facturer’s instructions. In our case, cells were incubated with
FLICA 660 dye for 1 h.
Yeast Strain Expressing AID-ICAD/CAD—Saccharomyces
cerevisiae (strain BY25602: Genotype MATa ura3-1::GAL-
OSTIR1-9myc(URA3)ade2-1 his3-11,15 lue2-3,112trp1-1 can1-
100) was obtained from the Yeast Genetic Resource Centre,
Osaka, Japan.HA-taggedmCAD (12) was amplified by PCRusing
primers (CTGAATTCGATGTGCGCGGTGCTC and CTGAT-
ATCTCACTAGCGCTTCCG), cloned into theEcoRI andEcoRV
sites of the pYM-N36 plasmid (MET25 promoter: HA-mCAD),




CCAGAATACC), and then integrated into the His3 locus.
HA-tagged mICAD-L (12) was amplified by PCR using primers
(GGGCCCGGAGCTGGTGCAGGCGCTGGCCGCATCTT-
TTAC and GGTACCCTACGAGGAGTCTCG), cloned into the
ApaI andKpnI sites of thepNHK12plasmid (alcohol dehydrogen-
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ase I (ADH) promoter: AID-HA-mICAD-I), linearized by MfeI,
and then integrated into Trp1 locus.
Colony Formation Assay for Yeast—The engineered S. cerevi-
siae cells were grown overnight in YPR, then diluted in YPR/
YPG medium to A600  0.5. YPG medium induces OsTIR1
expression. Cells were grown for 1 h at 30 °C and diluted in
water to A600  0.3, 0.03, or 0.003. Cells were replicate-plated
on the following plates: YPR  auxin and YPG  auxin and
incubated at 30 °C for 2 days to allow colony formation.
RESULTS
To test our hypothesis that rapid destruction of ICAD is suf-
ficient to activate CAD and lead to cell death, we utilized an
auxin-inducible degron (AID) system (Fig. 1C) (27). We
replaced the endogenous chicken (Gallus gallus) ICAD-L/S
with AID-GFP-mICAD-L, a cassette that contains the AID
degron fused to GFP (to monitor expression) and murine
ICAD-L, taking advantage of ICAD/ knock-out chicken
DT40 cells that we established previously (22). In those cells,
the AID-GFP-mICAD-L is the only source of ICAD and regu-
lates the activity of endogenous chicken CAD.OsTIR1, a plant-
specific F-box protein, was further incorporated into those
cells, which we termed AGI:TIR (AID-GFP-mICAD-L:TIR1)
cells. OsTIR1 binds to endogenous Skp1, forming the SCFTIR1
ubiquitin ligase complex. The expression and correct localiza-
tion of tagged ICAD-L were confirmed using anti-AID mono-
clonal antibody and GFP fluorescence (Fig. 2, A and C).
The addition of auxin to AGI:TIR cells induced rapid deple-
tion of AID-GFP-tagged ICAD, leading to CAD activation,
caspase activation, and apoptosis. The number of GFP-positive
AGI:TIR cells declined within 1 h after auxin addition (Fig. 2B).
In parallel, speedy depletion of AID-GFP-mICAD-L protein
was observed by immunoblotting (Fig. 2C). This resulted in
CAD activation as demonstrated by the appearance of TUNEL-
positive cells and the formation of characteristic apoptotic bod-
ies (Fig. 3A, column a3, and 3C). Apoptotic chromatin conden-
sation in auxin-treated AGI:TIR cells was morphologically
indistinguishable from that in their counterparts treated with
etoposide, a drug known to induce apoptosis (Fig. 3a5) (28, 29),
as well as wild type cells treatedwith etoposide (Fig. 3A, column
a6). Comparable levels of internucleosomalDNAcleavagewere
observed in AGI:TIR cells treated with either auxin or etopo-
FIGURE 1. Schematic of our experimental system. A, conventional apopto-
tic pathway. B, hypothesis: Does rapid depletion of ICAD-L trigger CAD acti-
vation and cell death? C, experimental system using AGI:TIR1 cells. A plasmid
encoding OsTIR1 and AID-GFP-mICAD-L was transfected into ICAD/
CAD/ chicken DT40 cells. F-box protein OsTIR1 binds to endogenous Skp1
to form the SCFTIR1(Skp1-Cullin1-TIR1) complex. TIR1 binds to an AID tag
in the presence of auxin (27). SCFTIR1 ubiquitinates the AID tag and promotes
the degradation of AID-tagged ICAD protein by proteasome. We set out to
test whether rapid degradation of ICAD could activate CAD.
FIGURE 2. Addition of auxin induces rapid depletion of AID-mICAD-L in
vivo. A, paraformaldehyde-fixed AID-GFP-mICAD-L-expressing cells (AGI:TIR)
were stained with anti-AID mouse monoclonal antibody. B, the fraction of
GFP-positive cells was detected by flow cytometry after the addition of 125
Mauxin.C, depletionofAID-GFP-mICAD-Lprotein after the additionof auxin
was assessed by anti-GFP antibody. -Tubulin (-Tub) was a loading control.
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side (Fig. 3B). In contrast, no DNA fragmentation was observed
in auxin-treated wild type cells. Somewhat more pronounced
DNA fragmentation was detected in etoposide-treated wild
type cells as compared with AGI:TIR cells as discussed below.
To determine the time course of CAD activation following
loss of ICAD, we employed a TUNEL assay to directly measure
CAD function. The ratio of TUNEL-positive cells increased
from 8.4 to 20.5% during the initial 2 h after auxin addition,
indicating that CAD activation occurs within the first 2 h. The
ratio of TUNEL-positive cells subsequently decreased to 17.7%
(4 h) and 12.4% (6 h). This was unexpected and is likely
explained by the loss of cleaved DNA from the apoptotic cells
during centrifugation steps. If apoptosis was blocked by the
addition of a caspase inhibitor, 33.7% of cells remained
TUNEL-positive after a 6-h auxin treatment. This result dem-
onstrates that CAD activation occurred following proteasome-
mediated destruction of ICAD in AGI:TIR cells.
CAD normally functions downstream of caspases during
apoptotic execution (Fig. 1A). We therefore asked whether
CAD activation can subsequently lead to caspase activation,
thereby triggering the full activation of the apoptoticmachinery
(Fig. 1B). Indeed, caspases became progressively activated in
AGI:TIR cells from 2 h after auxin addition (Fig. 4, A and B).
This caspase activation was almost entirely suppressed by the
addition of 10 M caspase inhibitor (Fig. 4A).
We further examined CAD-induced changes using addi-
tional assays for cell death. Annexin V has a high affinity for
phosphatidylserine, which appears on the outer leaflet of the
plasmamembrane in a caspase-dependentmanner during apo-
ptosis in many cell types (30–33). Indeed, an increase in
annexin V binding was detectable within 4 h after the addition
of auxin to AGI:TIR cells, and nearly half of the auxin-treated
AGI:TIR1 cells became annexinV-positive by 6 h after the addi-
tion of auxin (Fig. 4C).
With the addition of the caspase inhibitor, the death of aux-
in-treated AGI:TIR cells was substantially suppressed (Fig. 4C),
FIGURE 3. Rapid degradation of ICAD-L is capable of activating CAD in
vivo, leading toDNA fragmentation andapoptotic chromatin condensa-
tion. A, TUNEL staining of the AGI:TIR cells at time 0 (column a1) or after a
5-h treatment with solvent (column a2), auxin (column a3), auxin caspase
inhibitor (column a4), or etoposide (Etop; column a5); wild type cells treated
with etoposide (column a6); or wild type cells treated with etoposide and
caspase inhibitor (column a7). B, wild type DT40 cells or the AGI:TIR cells were
treatedwith etoposide or auxin for 5 h. Internucleosomal DNAwas visualized
by agarose gel electrophoresis. A contrast-enhanced picture is shownwithin
the red boxed region.C, flowcytometry analysis of TUNEL assay at various time
points after the addition of auxin to the AGI:TIR1 cells. Bars show S.D. (n 3).
Casp inh, caspase inhibitor.
FIGURE 4. Ectopic activation of CAD is sufficient to induce caspase activa-
tionandcell death.AandB, caspase activationdetectedbyFLICA660 in vitro
caspase detection kit. AGI:TIR cells were treatedwith the indicated drugs and
analyzed by flow cytometry (A) or by microscopy (B). Bars show S.D. (n 3).
Casp inh, caspase inhibitor. C, cell death detected by annexin V assay. The
AGI:TIR cells were treated with the indicated drugs and analyzed by flow
cytometry. D, long term cell survival was examined in a colony formation
assay. Ratios between cells (either wild type or AGI:TIR cells) treated with
auxin or not are shown. Bars show S.D. (n  3). E, time course of events fol-
lowing activation of the cell suicide module.
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and apoptotic chromatin condensation remained at the rim
stage while apoptotic body formation was suppressed (Fig. 3A,
column a4). This mimicked the phenotype seen when etopo-
side and caspase inhibitor were added together to normal cells
(Fig. 3A, column a4 versus column 3a7). These results strongly
suggest that CAD activation triggers caspase activation in a
positive feedback loop to promote apoptosis (Fig. 4E).
Clonogenic assays indicated that nearly half of the auxin-
treated AGI:TIR cells failed to form colonies after auxin treat-
ment, whereas fewer than 10% of the auxin-treated wild type
cells were affected (Fig. 4D). It is important to note that the 50%
decrease in colony formation in auxin-treated AGI:TIR cells is
an underestimation of the toxicity of this module as discussed
below.
After confirming our hypothesis using the chickenDT40 cell
system, we decided to test whether a complete “AID-mICAD/
mCAD plus OsTIR1” cell suicide module will work in a differ-
ent organism, S. cerevisiae (Fig. 5). The auxin-inducible degron
system was originally developed for use in S. cerevisiae (27). In
addition, there is no homologue of CAD/ICAD in S. cerevisiae,
whichmakes this organism ideal to test this cell suicidemodule.
Engineered yeast cells expressing AID-mICAD/mCAD plus
OsTIR1 over a 100-fold range of concentrations were plated in
the presence or absence of auxin. No colony appearedwhen the
engineered yeast cells were plated in the presence of auxin. This
demonstrates the effectiveness of the module even in a species
that does not normally express CAD and ICAD.
DISCUSSION
In the present work, we demonstrate for the first time that
ectopic activation of the nuclease CAD is sufficient to induce
caspase-dependent apoptosis. These observations not only
place CAD both downstream and upstream of caspases during
apoptotic execution, but also provide a novel strategy to assure
eradication of genetically engineered organisms that are released
into the environment.
Previous results placed the nuclease CAD downstream of
executioner caspases during apoptotic cell demolition (Fig. 1A)
(12, 14, 15). Our observations, however, show that destruction
of ICAD by the proteasome in the continued presence of CAD
leads to caspase activation (Fig. 4, A and B) and triggers hall-
mark changes of apoptosis, including phosphatidylserine expo-
sure (Fig. 4C), chromatin condensation, and nuclear fragmen-
tation (Fig. 3A, column a3). Both phosphatidylserine exposure
and nuclear fragmentation are dependent on caspase-mediated
cleavages (32–34), supporting that CAD activation can lead to
downstream caspase activation. Consistent with this conclu-
sion, we observed increased affinity labeling of active caspases
after ICAD destruction (Fig. 4A). Importantly, the addition of a
broad spectrum caspase inhibitor almost entirely suppressed
the caspase activation (Fig. 4A) and decreased auxin-induced
annexinVbinding (Fig. 4C) and nuclear fragmentation (Fig. 3A,
column a4).
Following ICAD destruction, we observed an initial rise in
TUNEL-positive cells followed by a subsequent decline at the 4-
and 6-h timepoints.Webelieve that this is a technical artifact of
theTUNEL assay, which requires fixation and permeabilization
of cells followed by repeated washing by centrifugation. Initial
experiments describing DNA cleavage in apoptosis actually
exploited this release of cleaved DNA from permeabilized apo-
ptotic cells (35, 36), and we suggest that loss of the fragmented
DNA from apoptotic cells could produce a decline in the
TUNEL signal detected by flow cytometry. Consistent with this
hypothesis, if we blocked the induction of apoptosis with a
caspase inhibitor, the percentage of TUNEL-positive cells after
ICAD destruction stayed high.
When all of our data are combined, the time course of induc-
tion of the cell suicide machinery can be recognized (Fig. 4E).
After auxin addition, most ICAD was degraded by the protea-
some within 1 h. This triggered CAD activation within 2 h.
Subsequently, caspase activation was evident after 4 h, and this
corresponded with an increase in cell death. These observa-
tions provide the first evidence for a positive feedback loop
from CAD to caspases during apoptosis.
Additional experiments indicated that the “AID-GFP-
mICAD plus OsTIR” module can eradiate unwanted cells. Our
studies in yeast (Fig. 5) indicate that this system can kill cells
even if they do not have an endogenous CAD/ICAD system.
Parallel observations in vertebrate cells demonstrate that this
system rapidly diminishes viability of AID-GFP-mICAD-ex-
pressing cells (Fig. 4). Our observation that 50% of cells lost the
ability to form colonies within 6 h likely represents an underes-
timation of the efficacy of this module, as 70% of the cells
expressed vanishingly small amounts of AID-GFP-mICAD by
flow cytometry at the time of auxin addition (Fig. 2B). The
residual cell survival and decreased extent of DNA fragmenta-
tion observed in AGI:TIR cells (Fig. 2B) likely arise from a
reduced amount of ICAD expression in those cells. Indeed, we
obtained no stable lines in which all cells were GFP-positive by
flow cytometry analysis, and theGFP-positive population grad-
ually declined in culture.We suspect that low level spontaneous
cleavage of ICAD may provide a selection for cells that have
silenced the module, a technical point that needs to be
addressed in future experiments.
In summary, we have developed a cell suicide module con-
sisting of AID-mICAD/mCAD plus OsTIR1, which works in
both vertebrate cells and yeast. Our data demonstrate that
rapid degradation of ICAD in vertebrate cells is sufficient to
activate CAD, leading to apoptotic death. This killing is
largely caspase-dependent, which indicates that there must
be a positive feedback loop between activated CAD, DNA
damage, and caspase activation. Importantly, our result is
FIGURE 5. Ectopic activation of CAD kills S. cerevisiae. Serial dilutions of
S. cerevisiaeexpressing the indicatedelementswereplated in thepresenceor
absence of 125 M indoleacetic acid.
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the first to show that ectopic activation of endogenous CAD
can kill healthy, non-apoptotic cells. This suggests the pos-
sibility that the CAD/ICAD interaction could potentially be
harnessed for elimination of unwanted cells. The ability to
create synthetic organisms for use in biotechnology and
genetically modified cells for use in potential therapies raises
the important question of how those cells can be controlled
once released among other normal cells or into the environ-
ment (37). We speculate that further developments outfit-
ting genetically engineered organisms with this suicide mod-
ule might provide a novel safety mechanism to eliminate
such organisms if they are released into the normal environ-
ment where auxin is routinely present.
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